Company: RGNT
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061821
Chunk: 179

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-07-07
Form: F-1/A
Chunk 179
---
 in which a controlling shareholder has a personal interest, and an engagement of the company,
directly or indirectly, with a controlling shareholder or a controlling shareholder’s relative (including through a corporation
controlled by a controlling shareholder), regarding the company’s receipt of services from the controlling shareholder, and if
such controlling shareholder is also an office holder or employee of the company, regarding his or her terms of employment, in each case
with a term of more than three years requires the abovementioned approval every three years, however, transactions not involving the
receipt of services or compensation can be approved for a longer term, provided that the audit committee determines that such longer
term is reasonable under the circumstances. In addition, transactions with a controlling shareholder or a controlling shareholder’s
relative who serves as an officer in a company, directly or indirectly (including through a corporation under his control), involving
the receipt of services by a company or their compensation can have a term of five years from the company’s initial public offering
under certain circumstances.

<div align='center'>106</div>

Arrangements regarding the
compensation, indemnification or insurance of a controlling shareholder in his or her capacity as an office holder require the approval
of the compensation committee, board of directors and shareholders by a Special Majority and the terms thereof may not be inconsistent
with the company’s stated compensation policy.

Pursuant to regulations promulgated
under the Companies Law, certain transactions and arrangements with a controlling shareholder or his or her relative, or with directors
or office holders, which would otherwise require approval of a company’s shareholders, may be exempt from shareholder approval
under certain conditions.

The Companies Law requires
that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction with a controlling
shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in the vote in question.
Failure to so indicate will result in the invalidation of that shareholder’s vote. However, according to the Companies Law Regulations
(exemptions for companies whose securities are listed for trading on a stock exchange outside of Israel) 5760-2000 that apply to the
Company, by signing and submitting a proxy card, a shareholder declares and approves that he has no personal interest in the approval
of any of the items on a general meeting agenda that requires such declaration under the Companies Law, with the exception of a personal
interest that the shareholder positively informed the company about.

Disclosure of Compensation of